Introduction
TNFα is a pleiotrophic cytokine that possesses strong proinflammatory and immunostimulatory activities and can induce cellular responses that vary from cell proliferation to apoptosis, depending on tissue type, precise cellular context, timing and duration of TNFα action (43) . Previous studies have shown that it plays a crucial role in the pathophysiology of cardiovascular diseases. Extremely elevated levels of this mediator are observed after heart failure (27, 40) and TNFα signalling is associated with carotid atherosclerosis, while its inhibition reduces neointima formation in ApoE null mice (4, 7) .
The biological activities of TNFα are induced through binding to two cell surface receptors, tumor necrosis factor receptor 1 (TNFRp55) and tumor necrosis factor receptor 2 (TNFRp75). Both receptors have significant homologies in their extracellular domains with repeat cysteine-rich sequences, but they are functionally distinct. TNFRp75 appears to play a major role in the lymphoid system, whereas TNFRp55 is the main mediator of the inflammatory responses exerted by TNFα. Mice lacking TNFRp55 are resistant to endotoxic shock and TNFα-mediated cytotoxicity although highly susceptible to infection (25, 32, 34, 36, 38) . Although both receptors are expressed in most cell types, knockout mice lacking the TNFRp55 and TNFRp75 are normal, indicating that TNFα signalling is not required for normal mouse development and homeostasis under basal conditions (31).
TNFα signalling can also be an important concern in tissue regenerative and engineering approaches. Generation of living tissue replacements or transplantation of differentiated progenitors capable of rescuing organ function represents a promising Page 3 of 44 therapeutic potential for cardiovascular and chronic diseases (23, 33) . For instance, vascular progenitors and endothelial cells derived from stem cells can effectively repair damaged endothelial monolayer in an animal model of femoral artery injury (47, 51).
However, the transplanted cells will have to survive in a very hostile environment that is usually deprived of nutrients, blood supply and highly enriched in inflammatory mediators like cytokines. Even though it is still unclear whether transient secretion of factors from the circulating progenitor cells or replacement of the injured tissue from the newly differentiated cells is required, characterization of the inflammatory response of these progenitors will provide useful insight into the efficiency of such interventions.
ES cells have the ability to differentiate to a wide variety of cell types and thus represent an attractive target for cell-based repair therapies (9, 17, 26, 28) . In the present study, we investigated TNFα signalling in mouse embryonic stem cells (ES), ES cellderived endothelial progenitors (esEC) and ES cell-derived smooth muscle cells (esSMC). Our experiments show that ES and ES cell-derived vascular cells do not induce cytokine expression in response to TNFα stimulation. This is mainly due to low levels of 
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Methods
Cell culture
SMCs were isolated by enzymatic digestion of mouse aortas as described elsewhere (13, 22) and were cultured in DMEM supplemented with 15% FCS, 2mM Lglutamine and 100mg/l gentamicin. Mouse ES cells (D3) were obtained from ATCC (Manassas, VA, USA) and grown on gelatin-coated flasks. Cell passages 3-15 were used for experiments. To maintain the ES cells in an undifferentiated state, leukaemia inhibitory factor (LIF, 1000 U/mL) was added to the culture medium (DMEM (ATCC)) supplemented with 10% FCS, 2mM L-glutamine, 100mg/l gentamicin and 10 -4 M 2-mercaptoethanol (2-ME).
Endothelial progenitors derived from ES cells (esEC) were obtained as described previously (51), ES were plated on collagen IV slides and cultured in alpha-MEM supplemented with 10% FBS, 2mM L-glutamine, 100mg/l gentamicin and 5x10 -5 M 2-ME for four days. The cells were subsequently subjected to shear stress at 12 dyn/cm 2 for 24h. Expression of EC markers was detected by RT-PCR and confirmed by FACS.
esSMC were derived from ES cells cultured on type IV mouse collagen coated flasks grown as described previously (46) . In brief, Sca-1 + cells were sorted from the cell culture by magnetic labelling cell sorting (MACS) with anti-Sca-1 microbeads (Miltenyi Biotec, GmbH, Bergisch Gladbach, Germany). Sca-1 + cells were resuspended and cultured in fresh ES cell growth medium. For SMC differentiation, Sca-1 + cells were plated on collagen IV-coated dishes or flasks, and cultured in αMEM supplemented with 10% FCS and 5x10 -5 M 2-ME and 10ng/ml PDGF-BB (Sigma). esSMC passage 5 were used for all experiments. Expression of SMC markers was detected by RT-PCR and confirmed by FACS.
RNase Protection Assay (RPA)
Total RNA was extracted using the Qiagen kit according to the manufacturer's instructions. To estimate the expression of cytokines, Rnase Protection Assay was performed, using mCK2b, mCR4 and mCK5c multi probe template sets (RiboQuant, Pharmingen, San Diego, CA) and [α-32 P] UTP (Amersham Biosciences) according to the manufacturer's recommendations. The "RNase-protected" fragments were purified and resolved on a 5% sequencing gel and autoradiographed. The housekeeping gene L32 was used as a loading control.
Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted using the Qiagen kit according to the manufacturer's instructions and any potential contaminating chromosomal DNA was digested using the DNA-free kit (Ambion). The procedure used for RT-PCR was similar to that described elsewhere (1). In brief, 2 µg of RNA were converted to cDNA using Promega Reverse Transcription System (Promega, Madison WI). cDNA products were amplified by PCR using gene specific primers. The primers used were: TNFRp55 Forward "ACC AAG TGC CAC AAA GGA AC", TNFRp55 Reverse "CAC GCA CTG GAA GTG TGT CT", TNFα Forward "AGC CCC CAG TCT GTA TCC TT", TNFα Reverse "CTC CCT TTG CAG AAC TCA GG" IL-6 Forward "CGA TGA TGC ACT TGC AGA AA", IL-6   Reverse "GGA AAT TGG GGT AGG AAG GA", Sp1 Forward "ACA GCA GGT GGA   GAA GGA GA", Sp1 Reverse "TGA GGC TCT TCC CAC ACT GT", Sp3 Forward   "GCT CCA CCT TTT GTG TTT CC", Sp3 Reverse "TCT TGT TTC ACG GGC TTT TC", c-fos Forward "GGG GCA AAG TAG AGC AGC TA", c-fos Reverse "GGC TGC CAA AAT AAA CTC CA", GAPDH Forward "CGG AGT CAA CGG ATT TGG TCG TAT" and GAPDH Reverse "AGC CTT CTC CAT GGT GGT GAA GAC". PCR conditions were as follows: 94°C for 3 min and then 30 cycles for TNFRp55, TNFα, IL-6, Sp1, Sp3, c-fos or 26 cycles for GAPDH at 94°C for 30 sec, 58°C for 1 min and 72°C for 1 min, followed by 72°C for 10 min. PCR products were separated by agarose gel electrophoresis and visualized by ethidium bromide staining.
Real time polymerase chain reaction experiments were performed with the Brilliant SYBR Green QPCR core reagent kit (Stratagene), using the Mx4000 (Stratagene) real time thermocycler according to the company's instructions.
Amplification was performed with 40 cycles and an annealing temperature of 58°C. Copy numbers were calculated by the instrument's software from standard curves. The specificity of the amplification reaction was determined by a melting curve analysis. For quantification TNFRp55, TNFα and IL-6 mRNA expression were normalized to the house keeping gene GAPDH.
To determine the half life of TNFRp55 or c-fos, cells were treated with 5µg/ml actinomycin D for the indicated time and total RNA was harvested. Levels of TNFRp55 mRNA were analysed by quantitative real time PCR. Target mRNA levels were normalized to GAPDH mRNA expression. Gene expression levels at time 0 were set as 100. Values are means ±SD. Data presented are the sum of four independent experiments.
Plasmid Construct
Expression vector harboring sequences of the mouse TNFRp55 or c-fos promoters were created using genomic DNA from SMCs. The 5'-flanking region of the respective gene was amplified by PCR. The PCR product was then digested, gel purified and cloned into the pGL3-basic vector. Mutants pGL3p55(Sp1-MUT12), pGL3p55(Sp1-MUT3) and pGL3p55(AP1-MUT) were generated by PCR using pGL3p55(-373, -129) vector as a template and mutant pGL3p55(Sp1-MUT123) using pGL3p55(Sp1-MUT12) as a template. PCR products were gel purified and ligated. The expression vectors pShuttle(Sp1), pShuttle(Sp3), pShuttle(c-fos) and pShuttle(c-jun) encoding the mouse Sp1, Sp3, c-fos and c-jun proteins respectively, were generated by PCR using mouse cDNA as a template. The PCR product was then digested, gel purified and cloned into the pShuttle vector. All primers and cloning sites are shown in Table 1 . All vectors were verified by sequencing.
Transient Transfection
For transfection experiments, 5x10 4 the transfected cells and the plates were returned to the incubator and harvested 48h later.
The cells were then washed twice with ice cold PBS and lysed in the Reporter Lysis Buffer (Promega). Luciferase and the β-galactosidase activity were determined using luciferase and β-galactosidase enzyme assay systems respectively (Promega) and the latter was used to calculate transfection efficiency in each experiment. At least 3 independent transfections were performed in triplicate.
siRNA knockdown
The siRNA for control, Sp1 and c-fos were purchased from Ambion Ltd (Huntingdon, Cambridgeshire, UK). siRNA experiments were performed using the siIMPORTER (Millipore) according to the company's recommendations. In brief, ES cells were plated on gelatin-coated 12 well plates and 24h later, siRNA together with pGL3p55(-1263, -129) and pCMV-β-galactosidase were introduced into the cells with siIMPORTER. The untransfected and control siRNA transfected cells were included as control. The transfected cells were further cultured for 72h. Luciferase and the β-galactosidase activity were determined using luciferase and β-galactosidase enzyme assay systems respectively (Promega) and the latter was used to calculate transfection efficiency in each experiment. Samples were run in triplicates and the data presented are the sum of at least three independent experiments. Western blot analysis was performed to confirm Sp1 and c-fos gene knockdown.
Western Blot Analysis
The procedure used was similar to that described previously (49). Antibodies against TNFRp55, β-actin, SP1, SP3 and c-fos were from Santa Cruz Biotechnology.
Specific antibody-antigen complexes were detected by using the ECL Western Blot Detection Kit (Amersham Pharmacia Biotech UK).
Bisulfite modification
DNA bisulfite modification and purification was performed using the EZ-DNA for 1 min and 72°C for 1 min, followed by 72°C for 10 min. PCR products were gel purified and cloned into pGEM-T vector (Promega) according to the company's instructions and 20 colonies were purified as minipreps and screened for correct insertion.
In each case, ten independent clones were sequenced.
Chromatin Immunoprecipitation (ChIP)
The ChIP assays were performed as described previously (50) were eluted from the beads using 100 µl elution buffer (50 mM NaHCO 3 , 1% SDS). A total of 200 µl proteinase K solution was added to a total elution volume of 300 µl and incubated at 60°C overnight. DNA was extracted, purified, and then used to amplify target sequences by PCR. The primers used to amplify the TNFRp55 promoter were:
ChIP TNFRp55 Forward "CTT GGC CCT CTC CTC ACT CC", ChIP TNFRp55
Reverse "GAG AAG CTG AAA GTC AGA GG". Aliquots of chromatin were also analysed before immunoprecipitation and served as an input control.
Statistics
Statistical analyses were performed by one-way ANOVA, and p<0.05 was considered statistically significant.
Results
ES cells and ES-cell-derived vascular cells do not upregulate cytokine expression after TNFα challenge due to low levels of TNFα receptors
In order to assess the inflammatory response of embryonic stem cells (ES) and ES-cell-derived smooth muscle cells (esSMC), we treated these cells for 1 or 2 hours with TNFα and analysed the mRNA levels of various cytokines using RNase Protection Assay (RPA). Surprisingly, except MIF no significant cytokine mRNA levels were observed even after 2h of treatment ( Figure 1 ). Mature smooth muscle cells (SMC) were used as a positive control. Very low levels of cytokines were detected after prolonged exposure of the film but these levels were dramatically lower compared to those observed in mature cells at baseline and no cytokine upregulation in response to TNFα was identified.
Interestingly, esSMC constitutively expressed elevated levels of IP-10 and TCA-3 that
were not affected by the TNFα treatment ( Figure 1C ). Of note, this short term TNFα treatment does not affect cell proliferation rate.
TNFα elicits its biological activities through two structurally related but functionally distinct receptors, TNFRp55 and TNFRp75. Previous studies have shown that TNFRp55 mediates most of the inflammatory responses induced by TNFα and thus our studies focused on this receptor (8, 34) . To determine whether ES cells and ES-cellderived vascular cells do not upregulate inflammatory cytokine expression due to the low abundance of this receptor, we studied its expression levels. TNFRp55 mRNA ( Figure 2A and 2B) and protein ( Figure 2C ) was extremely low in ES cells compared to mature SMC. Similar results were also obtained for esSMC ( Figure 2D ) and endothelial progenitors derived from ES cells afer shear stress ( Figure 2E ).
Regulation of TNFRp55 expression in ES cells
Regulation of the mRNA decay rate is an important process in determining the abundance of cellular transcripts. Aiming to identify any differences in the TNFRp55 mRNA stability in the two cell lines, we estimated the half life of the transcript. As shown in Figure 3A , no differences in the mRNA degradation were detected.
In mammals, reversible methylation of cytosine is an epigenetic modification known to suppress gene expression (3, 39) . To explore the possibility that DNA methylation of the TNFRp55 promoter inhibits its expression in ES, we did a sequence analysis of the 5' flanking region. Two regions enriched in CpG dinucleotides were identified. In order to study the methylation state, bisulfite modification of isolated genomic DNA from embryonic stem cells and the mature SMCs and PCR amplification of Part TA and Part TB was performed. As shown in Figure 3B , only some random methylation events were observed at low frequency and the TNFRp55 promoter was largely unmethylated (11) . These results suggest that downregulation of TNFRp55 expression in ES cells involves the control of the transcription rate.
To define the minimal region in the mouse TNFRp55 promoter that is necessary and sufficient for gene expression, deletions ranging from -3794 to -177 upstream of the translation initiation site of TNFRp55 were cloned into pGL3-Basic vector and reporter activity was measured after transient transfection. A 244 bp fragment spanning residues -373 to -129 was identified to show extremely strong promoter activity, comparable to that observed from the 3.6 kb promoter fragment ( Figure 4A ). 
Trichostatin A upregulates TNFRp55 expression
Histone deacetylases have been shown to play a crucial role in ES cell differentiation (21) . To investigate whether HDAC can also regulate the inflammatory response of ES cells, we studied the effect of HDAC inhibition on TNFRp55 expression.
As shown in Figure 5A and Figure 5B , TSA an inhibitor of histone deacetylases induced a significant upregulation in TNFRp55 mRNA and could slightly induce TNFRp55
protein. Of note, the concentrations of the reagent used did not affect cell proliferation and did not induce apoptosis. Moreover, even very low levels of TSA could induce TNFRp55 expression in ES cells ( Figure 5C ). To verify whether the effect of this reagent on TNFRp55 mRNA levels was due to transcriptional regulation, transient transfection assays were performed. As shown in Figure 5D , significantly elevated promoter activity was observed in TSA treated cells. Additionally, the major TSA response element seems to be located within the 244bp fragment of the minimal promoter of TNFRp55, as the 3.6 kb promoter fragment displayed luciferase activity comparable to that observed with the 244 bp fragment (data not shown). Further analysis using mutation of Sp1 and AP1 putative binding sites revealed that both Sp1 and AP1 binding is essential for the upregulation of TNFRp55 promoter activity by TSA, as disruption of either site ablated the increase in luciferase activity observed after TSA treatment. To further test whether this upregulation of TNFRp55 expression in ES cells was sufficient to restore cytokine expression, we assessed TNFα and IL-6 mRNA levels after 1h of TNFα challenge using quantitative real time PCR. Indeed, significantly higher levels of cytokine mRNA were detected in TSA-pretreated cells in response to TNFα challenge ( Figure 5E and 5F).
The transcription factor AP-1 has been implicated in a large variety of biological processes including cell differentiation, proliferation and apoptosis. It is a dimer composed of members of the Fos, Jun and ATF families of proteins. c-fos/c-jun heterodimer is known to bind to the sequence element TGA(G/C)TCA, as the one detected in the TNFRp55 minimal promoter (15, 37) . Since mutation of the above site could abolish promoter activity, we performed a chromatin immunoprecipitation assay to identify possible binding to the upstream regulatory regions of the gene. As shown in To study whether increased binding of c-fos by TSA was due to upregulation of cfos expression, we studied the c-fos mRNA levels. As shown in Figure 6C significantly higher levels of c-fos were detected. More importantly, increased mRNA levels were observed after TSA treatment at concentrations as low as 10nM ( Figure 6D , right panel).
Interestingly, this induction occurred very early, after only 2 h of treatment. Levels peaked at 4h and remained significantly elevated even after 24h ( Figure 6D ). c-fos mRNA is known to be rapidly degraded (35) . To determine whether this upregulation involved mRNA stabilization rather than transcriptional process, ES cells were pretreated with the transcription inhibitor actinomycin D for 1h and then treated with TSA for 4h.
As indicated in Figure 6E , this pretreatment completely abrogated c-fos mRNA induction by TSA. Additional experiments were performed using cycloheximide that has been previously shown to block c-fos mRNA turnover. Combined treatment of TSA and the protein synthesis inhibitor resulted in significantly higher levels of c-fos mRNA than treatment with cycloheximide, suggesting that TSA leads to induction rather than inhibition of degradation of c-fos mRNA ( Figure 6F ). Aiming to identify any differences in the c-fos mRNA stability in TSA treated and untreated cells, we estimated the half life of the transcript. As shown in Figure 6G , no differences in the c-fos mRNA degradation were detected. To further determine the effect of TSA on c-fos transcriptional regulation, we studied the effect of TSA on the c-fos promoter activity. Our results reveal a robust upregulation of the luciferase activity ( Figure 6H Knockdown experiments of Sp1 and c-fos also support a synergistic role for the two factors in the TSA induction of TNFRp55. While in untreated ES cells siRNA for Sp1 and c-fos has no effect on the reporter activity, a strong downregulation in luciferase levels was observed when deacetylase activity is inhibited by TSA treatment of ES cells ( Figure 8B ).
Discussion
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